相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease
Gunnar Brinkmalm et al.
PROTEOMICS CLINICAL APPLICATIONS (2018)
Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40
Harald Hampel et al.
ALZHEIMERS & DEMENTIA (2018)
Alzheimer's disease in the omics era
Giulia M. Sancesario et al.
CLINICAL BIOCHEMISTRY (2018)
Vascular Risk Factors and Lesions of Vascular Nature in Magnetic Resonance as Predictors of Progression to Dementia in Patients with Mild Cognitive Impairment
Raul Romero-Sevilla et al.
CURRENT ALZHEIMER RESEARCH (2018)
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease
Flora H. Duits et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis
Stephanie Herman et al.
THERANOSTICS (2018)
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease
Per Johansson et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly
Rosalinde E. R. Slot et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Differential diagnosis of Alzheimer's disease using spectrochemical analysis of blood
Maria Paraskevaidi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
mixOmics: An R package for 'omics feature selection and multiple data integration
Florian Rohart et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Cognitive function in very old men does not correlate to biomarkers of Alzheimer's disease
V. Velickaite et al.
BMC GERIATRICS (2017)
Cystatin C in aging and in Alzheimer's disease
Paul M. Mathews et al.
AGEING RESEARCH REVIEWS (2016)
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Niklas Mattsson et al.
EMBO MOLECULAR MEDICINE (2016)
OpenMS: a flexible open-source software platform for mass spectrometry data analysis
Hannes L. Roest et al.
NATURE METHODS (2016)
Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Kaj Blennow et al.
ALZHEIMERS & DEMENTIA (2015)
The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies
Malin Wennstrom et al.
PLOS ONE (2015)
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort
Maartje I. Kester et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease
Konstantin Hellwig et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Are Blood-Based Protein Biomarkers for Alzheimer's Disease also Involved in Other Brain Disorders? A Systematic Review
Justin Tao Wen Chiam et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics-Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
Mikko Holtta et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Plasma protein profiling of Mild Cognitive Impairment and Alzheimer's disease using iTRAQ quantitative proteomics
Fei Song et al.
PROTEOME SCIENCE (2014)
Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease
Christoffer Rosen et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2014)
Plasma levels of lipocalin 2 and chitinase 3-like 1 protein in patients with amnestic mild cognitive impairment and Alzheimer's disease
Kyunghun Kang et al.
Alzheimers & Dementia (2013)
Apolipoprotein A-I: Insights from redox proteomics for its role in neurodegeneration
Jeriel T. R. Keeney et al.
PROTEOMICS CLINICAL APPLICATIONS (2013)
Identification of SPARC-like 1 Protein as Part of a Biomarker Panel for Alzheimer's Disease in Cerebrospinal Fluid
Baharak Vafadar-Isfahani et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010
Thomas G. Beach et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Activity-dependent neuroprotector homeobox protein: A candidate protein identified in serum as diagnostic biomarker for Alzheimer's disease
Ming-Hui Yang et al.
JOURNAL OF PROTEOMICS (2012)
Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer's disease
Jihye Choi et al.
JOURNAL OF NEUROLOGY (2011)
Peptide Fingerprinting of Alzheimer's Disease in Cerebrospinal Fluid: Identification and Prospective Evaluation of New Synaptic Biomarkers
Holger Jahn et al.
PLOS ONE (2011)
Reduced Levels of Amyloid-beta-Binding Proteins in Cerebrospinal Fluid from Alzheimer's Disease Patients
Sara F. Hansson et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
False Discovery Rates of Protein Identifications: A Strike against the Two-Peptide Rule
Nitin Gupta et al.
JOURNAL OF PROTEOME RESEARCH (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
P3-232: SNPs in SOAT1, TFAM, and CNDP1 are associated with cerebrospinal fluid amyloid-beta levels
John S.K. Kauwe et al.
Alzheimers & Dementia (2008)
Identification and validation of novel CSF biomarkers for early stages of Alzheimer's disease
Yan Hu et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
Proteomic identification of lower apolipoprotein A-I in Alzheimer's disease
HC Liu et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Mild cognitive impairment -: beyond controversies, towards a consensus:: report of the International Working Group on Mild Cognitive Impairment
B Winblad et al.
JOURNAL OF INTERNAL MEDICINE (2004)
A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease
O Carrette et al.
PROTEOMICS (2003)
分享论文
